Celestica (NYSE:CLS) Price Target Raised to $480.00

Key Points

• Canaccord Genuity raised Celestica’s price target to $480 from $455 and maintained a Buy rating, implying roughly 69% upside from the reported $283.70 share price. Analysts collectively rate the stock “Moderate Buy,” with an average target of $453.32.
• Celestica exceeded quarterly expectations, reporting $3.30 in EPS versus the $3.02 consensus and revenue of $5.74 billion versus $5.39 billion expected. Analysts project full-year EPS of $10.71, supported by strong AI infrastructure demand.
• Despite bullish analyst sentiment, risks include insider selling, elevated valuation, potential margin pressure and negative free cash flow expected in 2027 as the company invests heavily to pursue its ambitious growth targets.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS had its price objective hoisted by equities researchers at Canaccord Genuity Group from $455.00 to $480.00 in a research note issued on Thursday, BayStreet reports. The firm currently has a "buy" rating on the technology company's stock. Canaccord Genuity Group's price target points to a potential upside of 69.19% from the stock's current price.

Other equities research analysts have also issued reports about the company. FBN Securities initiated coverage on Celestica in a research report on Tuesday, September 15th. They set an "outperform" rating and a $375.00 target price on the stock. BMO Capital Markets reiterated an "outperform" rating and set a $400.00 price target on shares of Celestica in a report on Friday, October 23rd. Scotiabank assumed coverage on Celestica in a research report on Tuesday, August 11th. They set a "sector outperform" rating and a $500.00 price target on the stock. Stifel Nicolaus set a $500.00 price objective on Celestica in a research note on Tuesday, July 28th. Finally, The Goldman Sachs Group restated a "conviction-buy" rating and set a $435.00 price objective on shares of Celestica in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, Celestica has an average rating of "Moderate Buy" and an average price target of $453.32.

Celestica Price Performance

Shares of Celestica stock traded down $16.10 on Thursday, hitting $283.70. The company had a trading volume of 1,467,440 shares, compared to its average volume of 2,466,415. Celestica has a 52 week low of $244.51 and a 52 week high of $474.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.23 and a quick ratio of 0.68. The company has a market cap of $32.62 billion, a PE ratio of 26.85 and a beta of 2.01. The business has a 50-day simple moving average of $325.76 and a 200-day simple moving average of $331.62.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last announced its earnings results on Monday, October 26th. The technology company reported $3.30 EPS for the quarter, topping the consensus estimate of $3.02 by $0.28. Celestica had a return on equity of 39.96% and a net margin of 7.16%. The firm had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.39 billion. Research analysts expect that Celestica will post 10.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Mandeep Chawla sold 16,117 shares of the stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $369.32, for a total value of $5,952,330.44. Following the completion of the transaction, the chief financial officer owned 65,444 shares of the company's stock, valued at $24,169,778.08. This represents a 19.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Robert Mionis sold 98,453 shares of the firm's stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total transaction of $36,328,172.47. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 243,067 shares of company stock valued at $89,200,967. 1.10% of the stock is owned by company insiders.

Institutional Trading of Celestica

Institutional investors have recently bought and sold shares of the stock. Washington Trust Advisors Inc. acquired a new position in shares of Celestica during the 2nd quarter worth approximately $28,000. Elevation Wealth Partners LLC acquired a new stake in shares of Celestica during the 3rd quarter worth approximately $28,000. Ascentis Independent Advisors acquired a new stake in Celestica in the first quarter valued at approximately $29,000. Latitude Advisors LLC acquired a new position in Celestica in the 3rd quarter valued at approximately $40,000. Finally, Mather Group LLC. raised its stake in Celestica by 266.7% during the third quarter. Mather Group LLC. now owns 121 shares of the technology company's stock worth $44,000 after buying an additional 88 shares during the last quarter. Institutional investors and hedge funds own 67.38% of the company's stock.

More Celestica News

Here are the key news stories impacting Celestica this week:

• Positive Sentiment: Celestica raised its 2026 outlook after third-quarter revenue rose roughly 83% year over year and adjusted earnings more than doubled. Strong demand for AI networking, compute and custom ASIC infrastructure is driving the upgrade. CLS Raises 2026 Outlook as AI Demand Powers an Aggressive 2027 Ramp
• Positive Sentiment: Management set an ambitious 2027 revenue target of approximately $40 billion, implying nearly a doubling from the 2026 target. Cloud and networking revenue growth and strong hyperscaler demand support the long-term opportunity. Celestica Stock Cools Despite Q3 Earnings Power and AI Ramp
• Positive Sentiment: UBS raised its price target from $430 to $453 and maintained a Buy rating, signaling continued analyst confidence in Celestica’s AI growth prospects. UBS Group Stock Recommendations
• Neutral Sentiment: Unusually heavy options activity, including a sharp increase in call-option purchases, indicates elevated investor interest but does not establish a clear direction for the shares. Celestica Sees Unusually Large Options Volume
• Negative Sentiment: Investors are concerned that the aggressive expansion will require significant working-capital and capital-spending investment. Celestica expects negative free cash flow in 2027, while cash conversion has weakened and recent cash generation has benefited from receivables sales and higher payables. Celestica: Free Cash Flow Tells The Whole Story
• Negative Sentiment: The stock’s premium valuation leaves little room for execution mistakes. Margin pressure from lower-margin compute work, reliance on a concentrated group of hyperscaler customers and uncertainty over delivering the 2027 targets have outweighed the earnings beat and higher guidance. CLS Falls as AI Growth Meets Rising Execution Risks

Celestica Company Profile

Celestica Inc is a global provider of design, manufacturing, and supply chain solutions for original equipment manufacturers and other technology companies. The company helps customers develop, produce, and support complex hardware and integrated systems across their product life cycles.

Its services include product design and engineering, electronics and mechanical manufacturing, systems integration, testing, supply chain management, logistics, and after-market support. Celestica serves markets such as communications, enterprise and cloud computing, aerospace and defense, industrial technology, health technology, and capital equipment.

Headquartered in Toronto, Canada, Celestica operates a global network of manufacturing, engineering, and supply chain facilities serving customers in North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.